Back to feed
ETONEton Pharmaceuticals, Inc.
CIK 0001710340 · no recent filings · 0 insider transactions
Buy volume
$0
0 buy transactions
Sell volume
$0
0 sell transactions
Net flow
+$0
Net buying
Total flow
$0
0 priced transactions
Disclosure radarcross-source convergence
Institution-led2/5 sources
0/100
Recent disclosures · timeline
- Form 1442d ago
Proposed sale of 251,818 sh ($8.99M) · discretionary
- Form 1443d ago
Proposed sale of 25,000 sh ($875.3K) · discretionary
Price · ETON
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data1 fund holds$42.38M reported valueNet reducing(0 adding · 1 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| BlackRock Inc | 1,717,286 | $42.38M | 0.0% | Trim-1% |
Proposed sales · Form 144
selling intent · live SEC data2 notices$9.87M proposed to sell0/2 under a 10b5-1 plan
| Filed | Filer | Shares | Est. value | Approx. sale | Source of shares | Plan |
|---|---|---|---|---|---|---|
| 2d ago | Gruber James R. Officer | 251,818 | $8.99M | Jun 26, 2026 | Stock Option Exercies | Discretionary |
| 3d ago | Gruber James R. Officer | 25,000 | $875.3K | Jun 25, 2026 | Stock Option Exercise | Discretionary |
Recent insider transactions
No insider transactions recorded for ETON.